3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
7
Prostatic Neoplasms
6
Diabetes Mellitus, Insulin-Dependent, 12
6
Carcinoma, Non-Small-Cell Lung
6
Carcinoma, Hepatocellular
6
Melanoma
5
Breast Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
4
Neoplasms
4
Small Cell Lung Carcinoma
3
Recurrence
3
Head and Neck Neoplasms
3
Carcinoma, Renal Cell
3
Urinary Bladder Neoplasms
2
Recurrent Squamous Cell Lung Carcinoma
2
Ovarian Neoplasms
2
Mesothelioma
2
Lung Neoplasms
2
Liver Neoplasms
2
Fallopian Tube Neoplasms
2
Cholangiocarcinoma
2
Biliary Tract Neoplasms
2
Vascular Neoplasms
1
Uterine Cervical Neoplasms
1
Urothelial Cancer
1
Thyroid Neoplasms
1
Thyroid Cancer, Papillary
1
Testicular Neoplasms
1
Solid Tumor
1
Sarcoma, Synovial
1
Interventions
Gemcitabine
19
Cisplatin
11
Capecitabine
9
Oxaliplatin
7
Fluorouracil
5
pembrolizumab
4
Leucovorin
4
Sorafenib
3
Magnetic Resonance Spectroscopy
3
Erlotinib Hydrochloride
3
trifluridine tipiracil drug combination
2
regorafenib
2
cobimetinib
2
atezolizumab
2
Trastuzumab
2
Taxes
2
Specimen Handling
2
Platinum
2
N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine
2
Lapatinib
2
Biopsy
2
Bevacizumab
2
Albumin-Bound Paclitaxel
2
130-nm albumin-bound paclitaxel
2
1,2-diaminocyclohexaneplatinum II citrate
2
zanidatamab
1
varlilumab
1
vandetanib
1
tucatinib
1
trametinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Gallbladder Neoplasms
×
tremelimumab
×
Clear all
No trials found.